Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Schmid

Showing results (431-440 of 629) with videos related to

Pageof 63
Sort By:
Environmental Science & Technology|December 11, 2012
Effects of a combined Diesel particle filter-DeNOx system (DPN) on reactive nitrogen compounds emissions: a parameter studyNorbert V Heeb, Regula Haag, Cornelia Seiler, et al.
The Lancet. Gastroenterology & Hepatology|October 2, 2017
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trialMichel Bazinet, Victor Pântea, Valentin Cebotarescu, et al.
Frontiers in Immunology|May 22, 2023
Evaluation of triple negative breast cancer with heterogeneous immune infiltrationÁngela Quintana, Enrique Javier Arenas, Cristina Bernadó, et al.
Dermatology (Basel, Switzerland)|December 1, 2006
Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice. Analysis of a Swiss cohortDagmar Simon, Jann Lübbe, Brunello Wüthrich, et al.
Future Oncology (London, England)|August 1, 2023
TROPION-Breast02: Datopotamab deruxtecan for locally recurrent inoperable or metastatic triple-negative breast cancerRebecca A Dent, David W Cescon, Thomas Bachelot, et al.
Toxicology|October 2, 2004
Endocrine activity and developmental toxicity of cosmetic UV filters--an updateMargret Schlumpf, Peter Schmid, Stefan Durrer, et al.
Cardiovascular Diabetology|October 20, 2011
Eplerenone prevents salt-induced vascular stiffness in Zucker diabetic fatty rats: a preliminary reportMarkus Resch, Peter Schmid, Kerstin Amann, et al.
Environmental Science & Technology|July 16, 2015
Biofuel-Promoted Polychlorinated Dibenzodioxin/furan Formation in an Iron-Catalyzed Diesel Particle FilterNorbert V Heeb, Maria Dolores Rey, Markus Zennegg, et al.
Respiratory Medicine|August 27, 2020
Asthma rehabilitation at high vs. low altitude and its impact on exhaled nitric oxide and sensitization patterns: Randomized parallel-group trialLisa Basler, Stéphanie Saxer, Simon R Schneider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2017
Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR)Michael J Seckl, Christian H Ottensmeier, Michael Cullen, et al.
Pageof 63

Showing results (431-440 of 629) with videos related to

Sort By:
Pageof 63
Environmental Science & Technology|December 11, 2012
Effects of a combined Diesel particle filter-DeNOx system (DPN) on reactive nitrogen compounds emissions: a parameter studyNorbert V Heeb, Regula Haag, Cornelia Seiler, et al.
The Lancet. Gastroenterology & Hepatology|October 2, 2017
Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trialMichel Bazinet, Victor Pântea, Valentin Cebotarescu, et al.
Frontiers in Immunology|May 22, 2023
Evaluation of triple negative breast cancer with heterogeneous immune infiltrationÁngela Quintana, Enrique Javier Arenas, Cristina Bernadó, et al.
Dermatology (Basel, Switzerland)|December 1, 2006
Benefits from the use of a pimecrolimus-based treatment in the management of atopic dermatitis in clinical practice. Analysis of a Swiss cohortDagmar Simon, Jann Lübbe, Brunello Wüthrich, et al.
Future Oncology (London, England)|August 1, 2023
TROPION-Breast02: Datopotamab deruxtecan for locally recurrent inoperable or metastatic triple-negative breast cancerRebecca A Dent, David W Cescon, Thomas Bachelot, et al.
Toxicology|October 2, 2004
Endocrine activity and developmental toxicity of cosmetic UV filters--an updateMargret Schlumpf, Peter Schmid, Stefan Durrer, et al.
Cardiovascular Diabetology|October 20, 2011
Eplerenone prevents salt-induced vascular stiffness in Zucker diabetic fatty rats: a preliminary reportMarkus Resch, Peter Schmid, Kerstin Amann, et al.
Environmental Science & Technology|July 16, 2015
Biofuel-Promoted Polychlorinated Dibenzodioxin/furan Formation in an Iron-Catalyzed Diesel Particle FilterNorbert V Heeb, Maria Dolores Rey, Markus Zennegg, et al.
Respiratory Medicine|August 27, 2020
Asthma rehabilitation at high vs. low altitude and its impact on exhaled nitric oxide and sensitization patterns: Randomized parallel-group trialLisa Basler, Stéphanie Saxer, Simon R Schneider, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2017
Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Pravastatin Added to First-Line Standard Chemotherapy in Small-Cell Lung Cancer (LUNGSTAR)Michael J Seckl, Christian H Ottensmeier, Michael Cullen, et al.
Pageof 63